Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real

Autores:: López Montanero, Edith Elizabeth
Moscoso Solórzano, Grace Támara
Alvarado Villa, Geovanny
Maldonado Guerrero, Bella Irma
Frías Toral, Evelyn Paola
Jiménez Jiménez, Fanny Maribel
Iglesias Arreaga, Adriana Lissette

Tipo de recurso:: Article of journal

Fecha de publicación:: 2020

Institución:: Universidad de Cartagena

Repositorio:: Repositorio Universidad de Cartagena

Idioma:: spa

id	UCART2_3a4981a63877252fcd2fd1b590d2440a
oai_identifier_str	oai:repositorio.unicartagena.edu.co:11227/13258
network_acronym_str	UCART2
network_name_str	Repositorio Universidad de Cartagena
repository_id_str
dc.title.spa.fl_str_mv	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
dc.title.translated.eng.fl_str_mv	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
title	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
spellingShingle	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real Citomegalovirus Infecciones por citomegalovirus Receptores de trasplantes Reacción en cadena de la polimerasa.
title_short	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
title_full	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
title_fullStr	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
title_full_unstemmed	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
title_sort	Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real
dc.creator.fl_str_mv	López Montanero, Edith Elizabeth Moscoso Solórzano, Grace Támara Alvarado Villa, Geovanny Maldonado Guerrero, Bella Irma Frías Toral, Evelyn Paola Jiménez Jiménez, Fanny Maribel Iglesias Arreaga, Adriana Lissette
dc.contributor.author.spa.fl_str_mv	López Montanero, Edith Elizabeth Moscoso Solórzano, Grace Támara Alvarado Villa, Geovanny Maldonado Guerrero, Bella Irma Frías Toral, Evelyn Paola Jiménez Jiménez, Fanny Maribel Iglesias Arreaga, Adriana Lissette
dc.subject.spa.fl_str_mv	Citomegalovirus Infecciones por citomegalovirus Receptores de trasplantes Reacción en cadena de la polimerasa.
topic	Citomegalovirus Infecciones por citomegalovirus Receptores de trasplantes Reacción en cadena de la polimerasa.
publishDate	2020
dc.date.accessioned.none.fl_str_mv	2020-11-27 00:00:00
dc.date.available.none.fl_str_mv	2020-11-27 00:00:00
dc.date.issued.none.fl_str_mv	2020-11-27
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	2215-7840
dc.identifier.uri.none.fl_str_mv	https://hdl.handle.net/11227/13258
dc.identifier.doi.none.fl_str_mv	10.32997/rcb-2015-2983
dc.identifier.eissn.none.fl_str_mv	2389-7252
dc.identifier.url.none.fl_str_mv	https://doi.org/10.32997/rcb-2015-2983
identifier_str_mv	2215-7840 10.32997/rcb-2015-2983 2389-7252
url	https://hdl.handle.net/11227/13258 https://doi.org/10.32997/rcb-2015-2983
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Ciencias Biomédicas
dc.relation.bitstream.none.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2983/2516
dc.relation.citationedition.spa.fl_str_mv	Núm. 1 , Año 2015
dc.relation.citationendpage.none.fl_str_mv	59
dc.relation.citationissue.spa.fl_str_mv	1
dc.relation.citationstartpage.none.fl_str_mv	53
dc.relation.citationvolume.spa.fl_str_mv	6
dc.relation.references.spa.fl_str_mv	Jawezt E, Melnick A, Adelberg E. Microbiología médica, 25th ed. México: Mc Graw Hill, 2011. 449 págs. Villasís A, Mosqueda JL. Infecciones en trasplante de médula ósea. RevInvestClin. 2005; 57(2):381-6. Gutiérrez J, Cruz L. Estudio de la seroprevalencia de la infección por citomegalovirus a través de la concentración sérica de IgG en un hospital de tercer nivel. RevMexPatolClin. 2008;55(4):175-86. Bhadauria D, Sharma RK, Kaul A, Prasad N, Gupta A, Gupta A, et al. Cytomegalovirus disease in renal transplant recipients: a single-center experience. Indian J Microbiol. 2012 Sep;52(3):510-5. Sagedal S, Hartmann A, Nordal, K, Osnes K, Leivestad T, Foss A, et al. Impact Of Early Cytomegalovirus Infection And Disease On Long - Term Recipient And Kidney Graft Survival. Kidney Int. 2004;66:329-37. Briganti E, Russ G, Graeme R, McNeil J, Atkins R, et al. Risk of renal allograft loss from recurrent glomerulonephritis. NEngl J Med. 2002;347(2):103-9. Onuigbo M, Haririan A, Ramos E, Klassen D, Wali R, Drachenberg C. Cytomegalovirus–Induced glomerular vasculopathy in renal allograft: A report of two cases. AJT. 2002;2:684-6. Tomlinson L, Boriskin Y, McPhee I, et al. Acute citomegalovirus infection complicated by collapsing glomerulopathy. NDT. 2003;18:187-9. Fishman J, Rubin R. Medical progress: infection in organ–transplant recipients. NEJM. 1998;338(24):1741-51 Murray BM, Brentjens J, Amsterdam D, Holwill S, Rice P. Monitoring and diagnosis of cytomegalovirus infection in renal transplantation. J Am Soc Nephrol. 1997;8(9):1448–57. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–51. Pouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged, A, Tardy JC, Bosshard S,et al. Cytomegalovirus infection-an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation. 1993;55(4):851–7. Schroeder R, Michelon T ,Yo F , Bortolotto A, ämmerhirt E, Oliveira J, et al. Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. Transplant Proc. 2004;36(4):896–8. Murray BM, Subramaniam S. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Transpl Infect Dis. 2004;6(1):3–9. Lebranchu Y, Bridoux F, Büchler M, Meur Y, Etienne I, Toupance O, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Trans. 2002;2:48–56. Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004;78(4):584–90. Nemati E, Eizadi M, Moghani Lankarani M, Kardavani B, Khoddami HR. Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis. Transplant Proc. 2007;39:987–89. Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K, et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant. 2004;10:49–57. Nichols W, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185:273–82. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543–558. Tey SK, Kennedy GA, Cromer D, et al. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications. PLoS One. 2013 Oct 11;8(10):e74744.. Xiao HW, Luo Y, Lai XY, Shi M, Tan M. Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes. Bone Marrow Transplant. 2014;49:241-247. Rasheed W, Ghavamzadeh A, Hamladji R, Ben T, Alseraihy A, Abdel F, et al Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey. Hematol Oncol Stem Cell Ther. 2013;6(1):14-9. doi: 10.1016/j.hemonc.2013.04.001. Epub 2013 Apr 6. Barkam C, Kamal H, Dammann E, Diedrich H , Buchholz S, Eder M , et al. Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Bone Marrow Res. 2012;2012:874601. Epub 2012 Dec 3. Pergam SA, Xie H, Sandhu R, Pollack M, Smith J, Ilieva , et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant. 2012 Sep;18(9):1391-400. Yi ES, Kim YJ. Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients.Yonsei Med J. 2012 Mar; 53(2):393-400. Farfán M, Torres J, Vergara A, Donoso G, Alba A, París C, et al. Comparación de las técnicas de reacción de polimerasa en cadena en tiempo real y antigenemia para la detección de citomegalovirus en sangre de niños sometidos a trasplantes. Rev Chil Infect. 2011; 28 (2): 113-17. Gimeno C, Solano C, Latorre JC, Hernández JC, Clari MA, Remigia MJ, et. al. Quantiﬁcation of DNA in plasma by an automated real-time PCR assay (Cytomegalovirus PCR Kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol. 2008; 46(10): 3311–18. Pacheco M, Madero L. Oncología pediátrica. Psioncología. 2003; 0(1):107-116. Díaz A, de la Caridad M, Resik S. Infecciones por citomegalovirus. RevCubana MedGenIntegr. 1998;14(3):270-8.
dc.rights.spa.fl_str_mv	Revista Ciencias Biomédicas - 2020
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Revista Ciencias Biomédicas - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Cartagena
dc.source.spa.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2983
institution	Universidad de Cartagena
bitstream.url.fl_str_mv	https://repositorio.unicartagena.edu.co/bitstreams/0284687e-6263-4585-9ddb-1aee33a7c680/download
bitstream.checksum.fl_str_mv	78db0805e05e56f9d4ca656a610c98c8
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Biblioteca Digital Universidad de Cartagena
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1814214076754034688
spelling	López Montanero, Edith ElizabethMoscoso Solórzano, Grace TámaraAlvarado Villa, GeovannyMaldonado Guerrero, Bella IrmaFrías Toral, Evelyn PaolaJiménez Jiménez, Fanny MaribelIglesias Arreaga, Adriana Lissette2020-11-27 00:00:002020-11-27 00:00:002020-11-272215-7840https://hdl.handle.net/11227/1325810.32997/rcb-2015-29832389-7252https://doi.org/10.32997/rcb-2015-2983application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2983/2516Núm. 1 , Año 2015591536Jawezt E, Melnick A, Adelberg E. Microbiología médica, 25th ed. México: Mc Graw Hill, 2011. 449 págs.Villasís A, Mosqueda JL. Infecciones en trasplante de médula ósea. RevInvestClin. 2005; 57(2):381-6.Gutiérrez J, Cruz L. Estudio de la seroprevalencia de la infección por citomegalovirus a través de la concentración sérica de IgG en un hospital de tercer nivel. RevMexPatolClin. 2008;55(4):175-86.Bhadauria D, Sharma RK, Kaul A, Prasad N, Gupta A, Gupta A, et al. Cytomegalovirus disease in renal transplant recipients: a single-center experience. Indian J Microbiol. 2012 Sep;52(3):510-5.Sagedal S, Hartmann A, Nordal, K, Osnes K, Leivestad T, Foss A, et al. Impact Of Early Cytomegalovirus Infection And Disease On Long - Term Recipient And Kidney Graft Survival. Kidney Int. 2004;66:329-37.Briganti E, Russ G, Graeme R, McNeil J, Atkins R, et al. Risk of renal allograft loss from recurrent glomerulonephritis. NEngl J Med. 2002;347(2):103-9.Onuigbo M, Haririan A, Ramos E, Klassen D, Wali R, Drachenberg C. Cytomegalovirus–Induced glomerular vasculopathy in renal allograft: A report of two cases. AJT. 2002;2:684-6.Tomlinson L, Boriskin Y, McPhee I, et al. Acute citomegalovirus infection complicated by collapsing glomerulopathy. NDT. 2003;18:187-9.Fishman J, Rubin R. Medical progress: infection in organ–transplant recipients. NEJM. 1998;338(24):1741-51Murray BM, Brentjens J, Amsterdam D, Holwill S, Rice P. Monitoring and diagnosis of cytomegalovirus infection in renal transplantation. J Am Soc Nephrol. 1997;8(9):1448–57.Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–51.Pouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged, A, Tardy JC, Bosshard S,et al. Cytomegalovirus infection-an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation. 1993;55(4):851–7.Schroeder R, Michelon T ,Yo F , Bortolotto A, ämmerhirt E, Oliveira J, et al. Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. Transplant Proc. 2004;36(4):896–8.Murray BM, Subramaniam S. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Transpl Infect Dis. 2004;6(1):3–9.Lebranchu Y, Bridoux F, Büchler M, Meur Y, Etienne I, Toupance O, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Trans. 2002;2:48–56.Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004;78(4):584–90.Nemati E, Eizadi M, Moghani Lankarani M, Kardavani B, Khoddami HR. Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis. Transplant Proc. 2007;39:987–89.Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K, et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant. 2004;10:49–57.Nichols W, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185:273–82.Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543–558.Tey SK, Kennedy GA, Cromer D, et al. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications. PLoS One. 2013 Oct 11;8(10):e74744..Xiao HW, Luo Y, Lai XY, Shi M, Tan M. Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes. Bone Marrow Transplant. 2014;49:241-247.Rasheed W, Ghavamzadeh A, Hamladji R, Ben T, Alseraihy A, Abdel F, et al Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey. Hematol Oncol Stem Cell Ther. 2013;6(1):14-9. doi: 10.1016/j.hemonc.2013.04.001. Epub 2013 Apr 6.Barkam C, Kamal H, Dammann E, Diedrich H , Buchholz S, Eder M , et al. Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Bone Marrow Res. 2012;2012:874601. Epub 2012 Dec 3.Pergam SA, Xie H, Sandhu R, Pollack M, Smith J, Ilieva , et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant. 2012 Sep;18(9):1391-400.Yi ES, Kim YJ. Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients.Yonsei Med J. 2012 Mar; 53(2):393-400.Farfán M, Torres J, Vergara A, Donoso G, Alba A, París C, et al. Comparación de las técnicas de reacción de polimerasa en cadena en tiempo real y antigenemia para la detección de citomegalovirus en sangre de niños sometidos a trasplantes. Rev Chil Infect. 2011; 28 (2): 113-17.Gimeno C, Solano C, Latorre JC, Hernández JC, Clari MA, Remigia MJ, et. al. Quantiﬁcation of DNA in plasma by an automated real-time PCR assay (Cytomegalovirus PCR Kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol. 2008; 46(10): 3311–18.Pacheco M, Madero L. Oncología pediátrica. Psioncología. 2003; 0(1):107-116.Díaz A, de la Caridad M, Resik S. Infecciones por citomegalovirus. RevCubana MedGenIntegr. 1998;14(3):270-8.Revista Ciencias Biomédicas - 2020https://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccesshttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2983CitomegalovirusInfecciones por citomegalovirusReceptores de trasplantesReacción en cadena de la polimerasa.Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo realPrevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo realArtículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlePublicationOREORE.xmltext/xml2656https://repositorio.unicartagena.edu.co/bitstreams/0284687e-6263-4585-9ddb-1aee33a7c680/download78db0805e05e56f9d4ca656a610c98c8MD5111227/13258oai:repositorio.unicartagena.edu.co:11227/132582024-09-05 15:30:31.093https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Ciencias Biomédicas - 2020metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com

Prevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo real

Publicaciones similares